AdobeStock 358683298

Cellular Origins acquires ACTIA Platform to enhance automated cell therapy production

Cellular Origins, a TTP company specialising in cell and gene therapy (CGT) manufacturing solutions, has announced the acquisition of the Autologous Cell Therapy Industrial Automation (ACTIA) Platform intellectual property. The acquisition is set to augment the company’s existing Constellation™ platform, which was launched in May 2023.

Autoimmune Encephalitis Mosaic 6

Together at the pulse of neurobiology

A unique portfolio of neurobiomarker tests The testing landscape for neurological diseases has expanded rapidly in recent years due to the characterisation of many novel biomarkers. With over 15 years of experience in neurological analytics, EUROIMMUN offers an unparalleled portfolio of assays for determination of more than 80 neurobiomarkers in autoimmune diseases, neurological infections and […]

Beckman Coulter Clar 1

Beckman Coulter Diagnostics is committed to innovation and growth in Ireland

In July 2024, Beckman Coulter Diagnostics announced a €10 million investment and 80 jobs for its site in mid-west Ireland. CLI caught up with Kevin O’Reilly, President of Beckman Coulter Diagnostics, to find out more about the company’s aims, its commitment to the site in Ireland, and how a world-class diagnostics development facility can be […]

Scherm­afbeelding 2024 08 19 om 19.57.35

INTEGRA Your reliable partner for productive pipettes

INTEGRA is a leading provider of high quality laboratory tools and consumables for liquid handling. We are committed to fulfilling the needs of laboratory professionals in research, diagnostics and quality control within the life sciences industry.

Biosynth Peptide Toolset

Biosynth’s custom peptide quotation tool now fully automatic

Biosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, has unveiled the next step in its custom peptide revolution.

Scherm­afbeelding 2024 08 16 om 16.39.10

Bio-Rad’s SpyLock technology accelerates bispecific antibody development

Bio-Rad Laboratories has announced the publication of a study in Nature Communications demonstrating the utility of its SpyLock technology for rapid generation and screening of bispecific antibodies. The research, titled “Engineered Reversible Inhibition of SpyCatcher Reactivity Enables Rapid Generation of Bispecific Antibodies”, highlights a novel method to modify the functional activity of SpyCatcher protein, potentially […]

Indica Labs Lung Macrodissect AI

Indica Labs unveils AI-powered macrodissection tool for lung cancer

In a significant advancement for molecular pathology, Indica Labs has launched Lung Macrodissect AI, a novel tool designed to streamline slide macrodissection workflows. The announcement marks a pivotal step in integrating artificial intelligence with digital pathology.

Lonnie Shoff

Medix Biochemica appoints IVD industry veteran to board

Medix Biochemica, a leading provider of in vitro diagnostics (IVD) raw materials, has announced the appointment of Lonnie Shoff to its Board of Directors. Shoff, formerly the President of the Clinical Diagnostics Division at Thermo Fisher Scientific, brings over 30 years of international healthcare experience to the role.

Synexa

Synexa Life Sciences embraces sustainable laboratory practices

In a notable move towards environmental responsibility within the life sciences sector, Synexa Life Sciences has announced its enrolment in the My Green Lab Certification Program. This strategic decision marks a significant step for the global biomarker and bioanalytical solutions provider in its quest to enhance the sustainability of its laboratory operations.

touchlight

Touchlight and LenioBio collaborate to advance rapid vaccine development

In a groundbreaking move towards accelerating pandemic response capabilities, Touchlight and LenioBio have announced a strategic partnership that could potentially transform the landscape of protein therapeutics development. This collaboration brings together two cutting-edge technologies in a bid to dramatically reduce the time required for vaccine production.